Cipla shares drop 2% after US FDA designates its Greece facility as OAI | Markets News Cipla share price fell 2.4 per cent to the day’s low of ₹1335.90 per share on the National Stock Exchange (NSE) By AJDesign77|2026-02-23T09:32:08+00:00February 23rd, 2026|Uncategorized|0 Comments Share This Story, Choose Your Platform! FacebookTwitterLinkedInRedditTumblrPinterestVkEmail About the Author: AJDesign77 Related Posts US Customs and Border Protection official says new process for tariff refunds could be ready … US Customs and Border Protection official says new process for tariff refunds could be ready … FDA’s Controversial Vaccine Chief Is Leaving the Agency … Again – MedPage Today FDA’s Controversial Vaccine Chief Is Leaving the Agency … Again – MedPage Today FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss US Tells Tariff Refund Judge It Can’t Comply With Order – Bloomberg US Tells Tariff Refund Judge It Can’t Comply With Order – Bloomberg Court overturns Trump tariffs, leading to refunds for thousands | Watch – MSN Court overturns Trump tariffs, leading to refunds for thousands | Watch – MSN